Galderma Group AG (FRA:PY30) EPS (Diluted) : € (TTM As of Jun. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG EPS (Diluted)?

Galderma Group AG's Earnings per Share (Diluted) for the six months ended in Jun. 2024 was €0.04.

Galderma Group AG's EPS (Basic) for the six months ended in Jun. 2024 was €0.04.

Galderma Group AG's EPS without NRI for the six months ended in Jun. 2024 was €0.04.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Galderma Group AG EPS (Diluted) Historical Data

The historical data trend for Galderma Group AG's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG EPS (Diluted) Chart

Galderma Group AG Annual Data

Trend

EPS (Diluted)

Galderma Group AG Semi-Annual Data
	Jun23	Jun24
EPS (Diluted)	-	0.04

Competitive Comparison of Galderma Group AG's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Galderma Group AG's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Galderma Group AG's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Galderma Group AG's PE Ratio distribution charts can be found below:

* The bar in red indicates where Galderma Group AG's PE Ratio falls into.

Galderma Group AG EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Galderma Group AG's Diluted EPS for the fiscal year that ended in . 20 is calculated as

Diluted EPS (A: . 20 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(	-	)	/	0
	=

Galderma Group AG's Diluted EPS for the quarter that ended in Jun. 2024 is calculated as

Diluted EPS (Q: Jun. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(43.663	-	0)	/	1188.081
	=	0.04

Galderma Group AG (FRA:PY30) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Galderma Group AG EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Galderma Group AG's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Galderma Group AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (FRA:PY30) » Definitions » EPS (Diluted)

Comparable Companies

Traded in Other Exchanges

GALDY:USA GDERF:USA GALDz:UK GALD:Switzerland

Address

Zahlerweg 10, Zug, CHE, 6300

Website

https://www.galderma.com

Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.

Galderma Group AG Headlines

No Headlines